Insider · CIK 0001866284
Janet Huffman
Files at OGEN (ORAGENICS INC). First filing -, latest -.
In brief
Janet Huffman files SEC Form 4 as CEO and CFO at OGEN (ORAGENICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Janet Huffman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | OGEN ORAGENICS INC | AGrant or award Employee Stock Option (right to buy)derivative | +250,000 | $0.00 | $0 | 250,000 | Dec 15, 2025 |
Questions about Janet Huffman
Answered from the filings on this page, as of the latest one.
Is Janet Huffman buying or selling?
Janet Huffman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Janet Huffman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Janet Huffman has 0.
Where does Janet Huffman file Form 4?
Janet Huffman has filed Form 4 at OGEN (ORAGENICS INC) as CEO and CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.